Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients - PubMed (original) (raw)
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
J C Lee et al. Eur J Cancer. 2000 Apr.
Abstract
Solid tumours require neovascularisation for growth and metastasis. Vascular endothelial growth factor (VEGF) has been shown to be an important regulator of tumour angiogenesis. To examine the relevance of VEGF in the neoplastic transformation of human colon, we analysed protein expression in a total 30 polyps and 145 colorectal carcinomas by immunohistochemistry. All adenoma specimens, regardless of histological differentiation, and normal colonic mucosa did not express VEGF. Amongst 90 patients with non-metastatic colorectal cancer, VEGF expression was observed in 43 (48%) cases, whilst 29 of the 55 patients (53%) with metastases expressed the angiogenic factor. Both the proportion and intensity of VEGF expression were positively associated with the progression of colon carcinogenesis. Tumours with the highest VEGF expression tended to correlate with patients' survival, although VEGF expression did not emerge as an independent risk factor in a multivariate analysis. After exclusion of the patients with distant metastases, both univariate and multivariate analysis did not indicate any prognostic value for the tissues with the highest VEGF expression. Our results suggest that VEGF may play a role in the progression of colon cancer, although evaluation of this angiogenic phenotype did not provide additional prognostic information compared with that obtained from Dukes' staging of the tumours.
Similar articles
- The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB. Hanrahan V, et al. J Pathol. 2003 Jun;200(2):183-94. doi: 10.1002/path.1339. J Pathol. 2003. PMID: 12754739 - Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
Ono T, Miki C. Ono T, et al. Am J Gastroenterol. 2000 Apr;95(4):1062-7. doi: 10.1111/j.1572-0241.2000.01909.x. Am J Gastroenterol. 2000. PMID: 10763960 - Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.
Chao C, Al-Saleem T, Brooks JJ, Rogatko A, Kraybill WG, Eisenberg B. Chao C, et al. Ann Surg Oncol. 2001 Apr;8(3):260-7. doi: 10.1007/s10434-001-0260-9. Ann Surg Oncol. 2001. PMID: 11314944 - Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy.
Harmey JH, Bouchier-Hayes D. Harmey JH, et al. Bioessays. 2002 Mar;24(3):280-3. doi: 10.1002/bies.10043. Bioessays. 2002. PMID: 11891765 Review. - Prognostic value of angiogenesis in gastro-intestinal tumours.
Chung YS, Maeda K, Sowa M. Chung YS, et al. Eur J Cancer. 1996 Dec;32A(14):2501-5. doi: 10.1016/s0959-8049(96)00382-6. Eur J Cancer. 1996. PMID: 9059339 Review. No abstract available.
Cited by
- TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Dinami R, Porru M, Amoreo CA, Sperduti I, Mottolese M, Buglioni S, Marinelli D, Maugeri-Saccà M, Sacconi A, Blandino G, Leonetti C, Di Rocco G, Verdina A, Spinella F, Fiorentino F, Ciliberto G, Biroccio A, Zizza P. Dinami R, et al. J Exp Clin Cancer Res. 2020 Jun 15;39(1):111. doi: 10.1186/s13046-020-01612-z. J Exp Clin Cancer Res. 2020. PMID: 32539869 Free PMC article. - Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy.
Verdaguer H, Tabernero J, Macarulla T. Verdaguer H, et al. Ther Adv Med Oncol. 2016 May;8(3):230-42. doi: 10.1177/1758834016635888. Epub 2016 Mar 11. Ther Adv Med Oncol. 2016. PMID: 27239240 Free PMC article. Review. - Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.
Chuang JP, Tsai HL, Chen PJ, Chang TK, Su WC, Yeh YS, Huang CW, Wang JY. Chuang JP, et al. Cells. 2022 Nov 23;11(23):3744. doi: 10.3390/cells11233744. Cells. 2022. PMID: 36497002 Free PMC article. Review. - Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review.
Rodriguez-Pascual J, Cubillo A. Rodriguez-Pascual J, et al. Curr Pharmacogenomics Person Med. 2017 Dec;15(2):81-85. doi: 10.2174/1875692115666170815161754. Curr Pharmacogenomics Person Med. 2017. PMID: 29657584 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical